Reported 5 months ago
The article discusses the current bull market in the stock market and highlights two growth stocks with long-term potential: CRISPR Therapeutics and Iovance Biotherapeutics. CRISPR Therapeutics recently received approval for its gene-editing treatment, while Iovance focuses on TIL treatments for cancer. Both companies have promising growth prospects and are seen as good investments for the long run, benefiting from the current bull market and beyond.
Source: YAHOO